Begin Main Content Area

Announcements

CHIP Provider Enrollment Claim Denial Alert (PDF)
Revised USP Compounding Standards (PDF) 
New Compounding Regulations (PDF)
Clarification of Opioid Continuing Education Requirement Under ABC-MAP* (PDF)
Evidence-Based Prescribing:  Tools You Can Use to Fight the Opioid Epidemic (PDF)
Act 6 of 2018 Reporting of Sanctions and Criminal Proceedings, Suspension and Civil Penalties (PDF)
Fentanyl Safety Recommendations (PDF)
Continuing Education Requirements for Pharmacist License Renewal (PDF)
DHS Training for Electronic Enrollment in CHIP (PDF)
FDA Warns of Potentially Counterfeit Drugs from Philadelphia Area Pharmacy
Opioid Education for Pharmacist Applications and Renewals Submitted After July 1, 2017 (PDF)

*NEW* - Drug Enforcement Administration (DEA) Renewal Change





Naloxone Frequently Asked Questions (PDF)
Naloxone Prescription for Overdose Prevention (Standing Order DOH-002-2016) (PDF)
Naloxone Standing Order for General Public


Act 31 of 2014 Mandated Child Abuse Recognition and Reporting

 

Other